Company intelligence / Profile preview

Remepy

New York, New York, United Statesremepy.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Remepy has demonstrated effects of its digital molecule interventions in clinical trials using fMRI imaging, blood and saliva samples analysis, and standardized questionnaires. It has shown that its patent-pending digital therapies can modulate blood biomarkers.

Therapeutic areas: OncologyOphthalmologyImmunologyNeurology
Modalities: Hybrid drugs (combination of traditional drugs with digital molecules)
Industry: Digital Health Medical Devices

Partnerships

Pharmaceutical companies (specific names not mentioned)

Beyond the preview

Go deeper on Remepy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Remepy.

Explore the full profile